Embla Medical

Embla Medical hf, headquartered in Iceland, has set ambitious climate commitments to address its carbon emissions. Although specific emissions data for the most recent year is not available, the company has established significant reduction targets. Embla Medical is committed to achieving net-zero greenhouse gas emissions across its entire value chain by 2050. In the near term, the company aims to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 79% by 2030, using 2019 as the baseline year. Additionally, it plans to cut its absolute Scope 3 emissions—covering purchased goods and services, fuel and energy-related activities, and transportation—by 25% by 2030, with a 2021 baseline. For the long term, Embla Medical has set a target to reduce its absolute Scope 1 and 2 emissions by 90% by 2050, while also aiming for a 90% reduction in Scope 3 emissions by the same year. These targets align with the Science Based Targets initiative (SBTi) and are consistent with the reductions necessary to limit global warming to 1.5°C. Through these commitments, Embla Medical hf demonstrates its dedication to sustainability and climate action within the healthcare equipment and supplies sector.